- Entry
- $0.04
- Final
- $0.0325 -18.8%
- Target
- —
- Score
- -1.00
Trulieve just became the first major U.S. cannabis company to uplist to the NYSE (trading as TRLV starting today, June 10). This is a big signal for the sector as federal rescheduling of medical marijuana to Schedule III paves the way for more institutional capital, traditional finance, and cross-border opportunities. Other MSOs are expected to follow. In this environment, companies with **robust medical cannabis platforms** — especially those with proven domestic insured medical channels and international export capabilities — become …
— ORIGINAL POST ·
Trulieve Uplists to NYSE Today — Herbal Dispatch (HERB / LUFFF) Positioned as Prime Medical Cannabis Play for MSO Buyout/Partnership with Strong Canadian Medical Platform + Large Medical Exports
· r/pennystocks
· Jun 10, 2026